SCHEMBL30586191

SCHEMBL30586191

O=c1c(-c2cccc(F)c2)coc2ccc(F)cc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.54
SMN1; SMN2 Q16637 4/20 0.52
KMT2A Q03164 3/20 0.52
MEN1 O00255 2/20 0.52
MAPT P10636 2/20 0.52
GABRP O00591 4/20 0.51
GABRD O14764 4/20 0.51
GABRA1 P14867 4/20 0.51
GABRB1 P18505 4/20 0.51
GABRG2 P18507 4/20 0.51
GABRB3 P28472 4/20 0.51
GABRA5 P31644 4/20 0.51
GABRA3 P34903 4/20 0.51
GABRA2 P47869 4/20 0.51
GABRB2 P47870 4/20 0.51
GABRA4 P48169 4/20 0.51
GABRE P78334 4/20 0.51
GABRA6 Q16445 4/20 0.51
GABRG1 Q8N1C3 4/20 0.51
GABRG3 Q99928 4/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29651755 1.00 PTPN1 (0.54) PTPN1SMN1; SMN2KMT2AMEN1MAPT
SCHEMBL8211 0.89 SMN1; SMN2 (0.56) PTPN1SMN1; SMN2KMT2AMEN1MAPT
SCHEMBL29651545 0.88 MIF (0.61) PTPN1SMN1; SMN2KMT2AMEN1MAPT
SCHEMBL8602 0.88 MIF (0.61) PTPN1SMN1; SMN2KMT2AMEN1MAPT
SCHEMBL10559664 0.84 ALOX12 (0.63) PTPN1SMN1; SMN2KMT2AMEN1MAPT
SCHEMBL4366639 0.80 KDM4E (0.73) SMN1; SMN2KMT2AMEN1MAPTKDM4E
SCHEMBL18311992 0.78 POLB (0.51) PTPN1SMN1; SMN2KMT2AMEN1MAPT
SCHEMBL4366282 0.77 MAPT (0.74) SMN1; SMN2KMT2AMEN1MAPTKDM4E
SCHEMBL29651565 0.76 KDM4E (0.56) SMN1; SMN2KMT2AMEN1MAPTKDM4E
SCHEMBL11616373 0.76 NPC1 (0.52) PTPN1SMN1; SMN2KMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117440826-A Administration of treatment with anti-CD 20/anti-CD 3 bispecific antibodies 基因泰克公司 2024-01-23 CN disclosed
CN-116917317-A Administration for treatment with anti-CD 20/anti-CD 3 bispecific antibody and anti-CD 79B antibody drug conjugates 基因泰克公司 2023-10-20 CN disclosed